Skip to Content Facebook Feature Image

Yili Wins Sixth Consecutive Thai FDA Quality Award, Strengthening Global Reputation for Excellence

Business

Yili Wins Sixth Consecutive Thai FDA Quality Award, Strengthening Global Reputation for Excellence
Business

Business

Yili Wins Sixth Consecutive Thai FDA Quality Award, Strengthening Global Reputation for Excellence

2025-08-15 11:52 Last Updated At:12:20

BANGKOK, Aug. 15, 2025 /PRNewswire/ -- The Thai Food and Drug Administration (FDA) recently announced the winners of its 2025 Quality Award. Recognized for its outstanding quality management, exceptional product quality, and broad market acceptance, Yili Group's Thailand subsidiary once again received the award. It is also the only Chinese-funded company to receive it this year.

This marks the sixth consecutive year, beginning in 2020, that Yili's Thailand subsidiary has received this honor. The award was presented by Thai Deputy Prime Minister and Minister of Public Health, Somsak Thepsuthin, and Thai FDA Deputy Secretary-General Lertchai Lertwut personally visited the booth of Cremo, a local ice cream brand owned by Yili, to commend the brand's achievements. This recognition is a testament not only to Yili's success in Thailand but also to the global leadership of Chinese companies in food quality.

The Thai FDA Quality Award is one of the country's most prestigious awards in the food and drug sector, known for its exceptionally rigorous criteria. The judging process scrutinizes every aspect of a company's operations, including raw material traceability, standardized production, final product testing, quality control throughout distribution, and corporate social responsibility.

This year, Yili's Thailand subsidiary particularly impressed the judging panel with its smart production management system, standardized facility signage, strict sanitation protocols, and industry-leading automation. The company also earned unanimous recognition from the judges for its stringent raw and auxiliary material controls, which exceed industry standards, and for its meticulous microbiological monitoring of every batch of semi-finished products.

The strong commitment of Yili's Thailand subsidiary to safety, health, and taste has led to steady growth in its market share. Its strong performance, combined with its dedication to quality management, enabled the company to stand out among more than a thousand participating businesses.

Currently, Yili's Thailand subsidiary produces 20,000 tons of ice cream annually, with sales growing at an average annual rate of over 13.7% over the past three years. Its brand, Cremo, is one of the fastest-growing ice cream brands in the Thai market, consistently ranking among the top three. The company also exports its products to 13 countries and regions, including Singapore, Malaysia, France, and Australia. Additionally, two of its new products received recognition at the 2025 World Dairy Innovation Awards, where Cremo Choco Crush Thai Tea was a finalist and Cremo Fruit Blast Grape was commended in the "Best Ice Cream" category.

Winning the Thai FDA Quality Award for a sixth consecutive year is a strong international endorsement of Yili's global strategy and robust quality management. This achievement marks a major milestone for Chinese food companies on the world stage. Moving forward, Yili will extend its stringent quality standards to more global markets, realizing its vision of "World Integrally Sharing Health" through products that are safer, healthier, and of superior quality.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Yili Wins Sixth Consecutive Thai FDA Quality Award, Strengthening Global Reputation for Excellence

Yili Wins Sixth Consecutive Thai FDA Quality Award, Strengthening Global Reputation for Excellence

Code Name: BlueSpot, a Go AI, is disclosed ahead of the handicap-match events in the 10th-anniversary year of the historic AlphaGo–Lee Sedol match.

NEW YORK, Jan. 15, 2026 /PRNewswire/ -- Issued by Code Name: BlueSpot Operations

Code Name: BlueSpot, the Go AI that embodies novel technology, is introduced today at the dawn of the 10th-anniversary year of the historic AlphaGo–Lee Sedol match.

As the milestone year begins to unfold, planning is underway for a Handicap-Adjustment Series as the main event—a series of public matches between BlueSpot and top-tier professional Go players. The intent is straightforward: to offer a clear perspective on the current discourse around AI—particularly the "AI bubble" narrative and its underlying assumptions—and to place demonstrable performance above private, unverifiable claims.

As a preliminary step, an Open Test—not a closed evaluation—in handicap-adjustment format is being prepared for the first half of 2026 (targeting March). It will be live-streamed online, feature multiple professional players drawn from a disclosed ranking range, and proceed under official refereeing. The venue will be announced in late January; final venue arrangements are underway across a small set of East Asian host locations.

BlueSpot is presented at this stage only as a code name. Further details will be disclosed with the main event. For the latest updates, visit https://codenamebluespot.com (Short link: https://cblue.spot).

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

10 Years Since AlphaGo, Code Name: BlueSpot Disclosed Ahead of Handicap-Match Events

10 Years Since AlphaGo, Code Name: BlueSpot Disclosed Ahead of Handicap-Match Events

Recommended Articles